Mirtazapine for use in medication overuse headache based on tension-type headache
US11207330B2 · kind B2 · utility
0Cited by
0References
12Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Oct 1, 2020 |
| Grant date | Dec 28, 2021 |
| Priority date | — |
| Expiry date | Oct 1, 2040 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P29/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Mirtazapine is useful for the treatment and/or prophylaxis of medication overuse headache based on tension-type headache. Moreover, a pharmaceutical composition and/or the use of mirtazapine for the manufacture of a medicament, are useful against medication overuse headache based on tension-type headache, and the treatment of medication overuse headache based on tension-type headache.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.